Aug 3–9

BRVE led a busy week with seven insiders deploying $69.4M in aggregate—the largest single-company insider buy of the period and a strong show of conviction from a cluster that included a 10% owner. EWAV followed with six buyers and a material 8-K catalyst that week, while OKYO also drew a six-person cluster despite minimal dollar volume. The week was marked by heavy biotech and SPAC activity across 43 companies, with four multi-insider clusters signaling coordinated confidence in the sector.